🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting opportunity to work in Medical Oncology in Waterford & the South East! publicjobs.ie/en/?option=com…

'Hello. My name is...' This #IWD2024, we remember Dr Kate Granger. Kate started a quiet revolution in the NHS when she started a campaign for staff to simply introduce themselves. Kate died in 2016 from sarcoma, but her legacy continues to change lives. #HelloMyNameIs

Very glad to share our real-world analysis of the efficacy and safety of ripretinib in 45 patients with advanced GIST treated in the 🇬🇧 expanded access program. A few points: 🧵 (1/5) mdpi.com/2072-6694/16/5… Robin Lewis Jones GIST Cancer UK

Dr Emmet O’Brien gives #AILCC24 a comprehensive overview on the negative health impacts of #smoking ➡️ estimated that a container of cigarettes causes 10 deaths 🚨Urgent need to denicontinise vapes and raise the legal smoking age to 21 #AILCC24 #IrishLungCancerAlliance IASLC #LCsM

🚨Calling all CARG Members!📷 Don't miss out on the opportunity to showcase your work at #SIOG2024. The abstract submission deadline is fast approaching. Submit your abstracts by 4/18 and be part of the forefront of #GeriOnc research! siog.org/events/siog-ev… #CallForAbstract

Má tá spéis agat sa Ghaeltacht agus níl an scannán 'An mar a chéile muid?' feicthe agat, molaim go mór é a fheiceáil. youtu.be/aAXxSNjf7Ng?si…

Mariana Brandao: What defines operable NSCLC? EORTC consensus guidelines: 🔸 T3N1 = ✅ (resectable) 🔸T3 single station N2 = ✅ 🔸T3 multi-station N2 = ❌ 🔸T3 Bulky N2 = most ❌ 🔸T4 N0/1 = ✅, unless infiltration of major structures #LCSM #BTOG24

🛬🇮🇪 ECO lands in Ireland next week to talk international collaboration & the #TimeToAccelerate Cancer Manifesto! Register now to watch our sessions online at the Joint Euro-American Forum on Cancer, 25-26 April 👉eventbrite.ie/e/the-joint-eu… #EUCancerManifesto #CancerHasNoBorders

Delighted to present our exciting trial in progress of induction Pembrolizumab with therapeutic HPV vaccine PRGN-2009 in HPV-OPC planned for curative Sx/CRT at #ASCO24 . Recruiting well and rapidly through the NCI in Bethesda under C. 'Harris' Floudas and Clint Allen @NIDCD.

Mnásome 💚 Ciara Mageean

Please donate to Colorectal Cancer Research Univ Hosp Waterford gofundme.com/f/7cggj5-color… Golf classic this Saturday Rathaspeck Manor! All welcome! Fiachra Cooke @LiamDevane Niamh Peter Neary

Comhghairdeas go léir 🎊

Don't miss your chance to register for the virtual ISMO After ASCO meeting - happening tomorrow from 7 to 9 p.m. 📨 [email protected] to register. Details & agenda: bit.ly/3RZIBbs Seamus O’Reilly MD PhD Jack Gleeson Fergus Keane Siobhan Gaynor Caitríona Goggin

What an incredibly brave woman. Huge respect and a great tribute to a wonderful man.. Sarcoma Ireland Sarcoma Cancer Ireland Irish Cancer Society Charles Gillham MD

🌍Today is the International Day of Friendship🌍 Some of our work has highlighted the critical role social connections play in healthy ageing. #FriendshipDay #HealthyAgeing #TILDA #SocialConnectedness

Dr Goggin and her co-investigators present a study revealing 57% cancer survivors have ⬇️ social networks. Only 37% of older patients had access to computer/internet 🖥️. ⬆️social isolation than general population. Caitríona Goggin #survonc #supponc doi.org/10.1093/oncolo…

Our #ESMOYOC star Liz Connolly presenting at #ESMO24 mini-oral #sarcoma session! 🚨prognostic value of 8-protein proteomics signature in LMS Great job Liz 👏 ESMO - Eur. Oncology #ESMOAmbassadors

World Gynae Oncology Day 2024 Including the Dip In Dunmore East by UHW consultants, staff & friends as part of GO Campaign. Well done to the dippers 🏊🏊‍♂️🥶 @IEHospitalGroup Ireland South Women & Infants Directorate NAS_Waterford HSE/SECH (now part of HSE Dublin and South East)

Most awaited presentation of the year by Patrick Schöffski - BRIGTHLINE-1 trial - Brigimadlin 🆚 doxo in 1st line DDLPS ❌negative trial - no improvement in PFS 🔸mPFS 8,4 vs 7.1m HR 0.79 🔸 ORR 22 vs8.6% ⏭️what next? #CTOS2024 CTOS

Morning > Afternoon for IO? Evidence is mounting—retrospective and now prospective (210 pts, randomized, PFS HR 0.42 but no PD-L1 strat). Given IO’s long half-life, maybe only the timing of the first dose matters. #ASCO2025